Biotest AG: Biotest receives approval for phase III clinical trial in pregnant women for prevention
DGAP-News: Biotest AG / Key word(s): Study26.08.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest receives approval for phase III clinical trial in pregnant women for prevention of CMV infection of the unborn baby Infection of the foetus with Cytomegalovirus (CMV...